Alisertib Induces Cell Cycle Arrest and Autophagy and Suppresses Epithelial-to-Mesenchymal Transition Involving PI3K/Akt/mTOR and Sirtuin 1-Mediated signaling pathways in Human Pancreatic Cancer Cells [Retraction]
Drug Design, Development and Therapy · 2026-06 · Volume 20 · 1-2
DOI: 10.2147/dddt.s633636 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-06. Verfasst von Feng Wang und 12 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, F., Li, H., Yan, X., Zhou, Z., Yi, Z., He, Z., Pan, S., Yang, Y., Wang, Z., Zhang, X., Yang, T., Qiu, J., & Zhou, S. S. (2026). Alisertib Induces Cell Cycle Arrest and Autophagy and Suppresses Epithelial-to-Mesenchymal Transition Involving PI3K/Akt/mTOR and Sirtuin 1-Mediated signaling pathways in Human Pancreatic Cancer Cells [Retraction]. Drug Design, Development and Therapy, Volume 20, 1-2. https://doi.org/10.2147/dddt.s633636
Vancouver
Wang F, Li H, Yan X, Zhou Z, Yi Z, He Z, et al. Alisertib Induces Cell Cycle Arrest and Autophagy and Suppresses Epithelial-to-Mesenchymal Transition Involving PI3K/Akt/mTOR and Sirtuin 1-Mediated signaling pathways in Human Pancreatic Cancer Cells [Retraction]. Drug Design, Development and Therapy. 2026;Volume 20:1-2. doi:10.2147/dddt.s633636
BibTeX
@article{Wang2026,
author = {Wang, Feng and Li, Hai and Yan, Xiao-Gang and Zhou, Zhi-Wei and Yi, Zhi-Gang and He, Zhi-Xu and Pan, Shu-Ting and Yang, Yin-Xue and Wang, Zuo-Zheng and Zhang, Xueji and Yang, Tianxing and Qiu, Jia-Xuan and Zhou, Shu-Feng S},
title = {Alisertib Induces Cell Cycle Arrest and Autophagy and Suppresses Epithelial-to-Mesenchymal Transition Involving PI3K/Akt/mTOR and Sirtuin 1-Mediated signaling pathways in Human Pancreatic Cancer Cells [Retraction]},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--2},
doi = {10.2147/dddt.s633636}
}
EUVIMED